qtr-one adjusted earnings per share $num-one.
qtr-three revenue $num-one billion versus refinitiv ibes estimate of $1.55 billion.
net interest expense is still expected to be about $num-one million for year-six.
qtrly organic revenue decreased num-one%.
expect over num-one% year-over-year growth in backlog in year-six.
qtrly net sales growth of num-one%.
sees fy capital expenditures of $num-one million to $2.0 billion.
sees restructuring in year-six to be approximately $num-one million.
qtr-three adjusted earnings per share $num-one excluding items.
compname reports qtr-two year-six results and announces $num-one million share repurchase authorization.
sees year-six total operating expenses of about $num-one million, driven by higher medical expenses, stock and incentive-based compensation and higher costs.
sees year-six capital expenditures of approximately $num-one million.
qtrly revenue was flat year-over-year compared to qtr-one of year-five.
qtr-one adjusted ebitda margin declined num-one basis points to num-two%.
qtrly organic sales increased nearly num-one% year-over-year.
qtrly adjusted ebitda margin decreased num-two basis points to num-one%.
